Found: 55
Select item for more details and to access through your institution.
Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant hodgkin lymphoma: Long-term outcomes from a 30-year experience.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 6, p. E103, doi. 10.1002/ajh.23989
- By:
- Publication type:
- Article
Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 5, p. 667, doi. 10.1111/ejh.13486
- By:
- Publication type:
- Article
Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 4, p. 476, doi. 10.1111/ejh.13469
- By:
- Publication type:
- Article
Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients.
- Published in:
- Advances in Hematology, 2017, p. 1, doi. 10.1155/2017/6527306
- By:
- Publication type:
- Article
Seronegative antibody‐mediated neurology after immune checkpoint inhibitors.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 5, p. 640, doi. 10.1002/acn3.547
- By:
- Publication type:
- Article
Allogeneic Hematopoietic Cell Transplantation Outcomes After Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma (CA209-039 and CheckMate 205).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S326, doi. 10.1016/j.clml.2017.07.136
- By:
- Publication type:
- Article
RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Partial engraftment following plerixafor rescue after failed sibling donor peripheral blood stem cell harvest.
- Published in:
- Transfusion, 2014, v. 54, n. 5, p. 1231, doi. 10.1111/trf.12429
- By:
- Publication type:
- Article
Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 7, p. 3789, doi. 10.1007/s12325-021-01764-0
- By:
- Publication type:
- Article
Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre.
- Published in:
- Nephrology Dialysis Transplantation, 2010, v. 25, n. 2, p. 419, doi. 10.1093/ndt/gfp488
- By:
- Publication type:
- Article
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity.
- Published in:
- Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00209
- By:
- Publication type:
- Article
Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01188-x
- By:
- Publication type:
- Article
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01177-0
- By:
- Publication type:
- Article
Checkpoint Inhibitors and the Changing Face of the Relapsed/Refractory Classical Hodgkin Lymphoma Pathway.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 11, p. 1477, doi. 10.1007/s11912-022-01292-2
- By:
- Publication type:
- Article
Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2009, v. 146, n. 4, p. 396, doi. 10.1111/j.1365-2141.2009.07761.x
- By:
- Publication type:
- Article
MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 4, p. 479, doi. 10.1111/j.1365-2141.2007.06680.x
- By:
- Publication type:
- Article
Adult T cell leukaemia/lymphoma (ATL) in pregnancy: A UK case series.
- Published in:
- EJHaem, 2021, v. 2, n. 1, p. 134, doi. 10.1002/jha2.142
- By:
- Publication type:
- Article
Older patients with Hodgkin Lymphoma: Walking the tightrope of efficacy and toxicity.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2022.1017787
- By:
- Publication type:
- Article
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.992137
- By:
- Publication type:
- Article
Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 6, p. 455, doi. 10.1111/ejh.12360
- By:
- Publication type:
- Article
T-cell/histiocyte-rich large B-cell lymphoma - transformation of Nodular lymphocyte predominant Hodgkin lymphoma in the bone marrow.
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 6, p. 550, doi. 10.1111/ejh.12278
- By:
- Publication type:
- Article
Identification and Characterization of Peripheral T-Cell Lymphoma-Associated SEREX Antigens.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023916
- By:
- Publication type:
- Article
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 4, p. 207, doi. 10.1007/s11899-019-00518-8
- By:
- Publication type:
- Article
A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Management of children and adults with all stages of nodular lymphocyte predominant Hodgkin lymphoma — All StAGEs: A consensus‐based position paper from the Hodgkin lymphoma subgroup of the UK National Cancer Research Institute.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 6, p. 679, doi. 10.1111/bjh.18169
- By:
- Publication type:
- Article
Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 5, p. 558, doi. 10.1111/bjh.18083
- By:
- Publication type:
- Article
Limited‐stage diffuse large B‐cell lymphoma: current management and challenges.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 508, doi. 10.1111/bjh.17359
- By:
- Publication type:
- Article
Care of haematology patients in an overwhelmed healthcare system.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 269, doi. 10.1111/bjh.17358
- By:
- Publication type:
- Article
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response‐adapted design in the first‐line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 63, doi. 10.1111/bjh.17073
- By:
- Publication type:
- Article
Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID‐19 pandemic.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 6, p. e224, doi. 10.1111/bjh.16782
- By:
- Publication type:
- Article
Care of haematology patients in a COVID‐19 epidemic.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. 241, doi. 10.1111/bjh.16620
- By:
- Publication type:
- Article
Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associated increased infection‐related toxicity.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 2, p. 185, doi. 10.1111/bjh.16070
- By:
- Publication type:
- Article
Efficacy of R‐GCVP in patients with late relapse of diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 6, p. e191, doi. 10.1111/bjh.16071
- By:
- Publication type:
- Article
Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R‐CHOP.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 4, p. e94, doi. 10.1111/bjh.15927
- By:
- Publication type:
- Article
Impact of graft‐versus‐lymphoma effect on outcomes after reduced intensity conditioned‐alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 547, doi. 10.1111/bjh.15685
- By:
- Publication type:
- Article
Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 555, doi. 10.1111/bjh.14665
- By:
- Publication type:
- Article
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 471, doi. 10.1111/bjh.14898
- By:
- Publication type:
- Article
NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 1, p. 43, doi. 10.1111/bjh.14177
- By:
- Publication type:
- Article
Results of a multicentre UK-wide retrospective study evaluating the efficacy of pixantrone in relapsed, refractory diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 6, p. 896, doi. 10.1111/bjh.14021
- By:
- Publication type:
- Article
Results of a large retrospective analysis of the effect of intended dose intensity of R- CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 3, p. 487, doi. 10.1111/bjh.13619
- By:
- Publication type:
- Article
A phase II trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 6, p. 886, doi. 10.1111/bjh.13333
- By:
- Publication type:
- Article
Immune checkpoint inhibition in lymphoid disease.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 3, p. 291, doi. 10.1111/bjh.13397
- By:
- Publication type:
- Article
Management and controversies of classical Hodgkin lymphoma in pregnancy.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 5, p. 613, doi. 10.1111/bjh.13327
- By:
- Publication type:
- Article
Long-term outcomes of autologous stem cell transplantation for peripheral T-cell lymphomas across the Thames Valley (1997-2012).
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 3, p. 452, doi. 10.1111/bjh.13226
- By:
- Publication type:
- Article
Time now to TORC the TORC? New developments in m TOR pathway inhibition in lymphoid malignancies.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 3, p. 336, doi. 10.1111/bjh.12945
- By:
- Publication type:
- Article
Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 1, p. 39, doi. 10.1111/bjh.12582
- By:
- Publication type:
- Article
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.571066
- By:
- Publication type:
- Article
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.01308
- By:
- Publication type:
- Article
A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Population Pharmacokinetic Modeling and Exposure–Response Assessment for the Antibody‐Drug Conjugate Brentuximab Vedotin in Hodgkin's Lymphoma in the Phase III ECHELON‐1 Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 6, p. 1268, doi. 10.1002/cpt.1530
- By:
- Publication type:
- Article